Key Segmentation
By Disease
-
Bacterial Enteric Disease
-
Viral Enteric Disease
-
Parasitic Enteric Disease
By Test Type
-
Immunoassay
-
Molecular
-
Conventional
-
Chromatography & Spectrometry
-
Other Test Types
By End-Use
-
Hospitals
-
Diagnostic Laboratories
-
Research & Academic Institutes
-
Other End-Users
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
The Enteric Disease Testing Market is expected to grow at a CAGR of 3.70% from 2026 to 2035.
The Enteric Disease Testing Market was valued at USD 4.08 Billion in 2025.
Rising global enteric disease incidence creating consistent diagnostic procurement motivation, and molecular multiplex panel adoption that improves diagnostic comprehensiveness and per-episode testing revenue simultaneously while delivering antibiotic stewardship and infection control benefits that create institutional procurement justification beyond individual test cost.
Bacterial Enteric Disease dominated the Enteric Disease Testing Market with approximately 54.31% share in 2025.
North America dominated the Enteric Disease Testing Market in 2025.